Pentacel (with vIPV) vaccine 0.5 ML Injection
- RxCUI
- 2585717
- RxNorm name
- Pentacel (with vIPV) vaccine 0.5 ML Injection
- Display name
- Pentacel (with vIPV) vaccine 0.5 ML Injection
- Full name
- Pentacel (with vIPV) vaccine 0.5 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125145 | Pentacel | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 67d5c665-ca88-49ba-b7d3-7145d9878cf0 | Pentacel (with vIPV) vaccine 0.5 ML Injection [PSN] · 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] [SBD] · Pentacel DTaP-IPV/Hib (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus (vIPV) and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)) 0.5 ML Injection [SY] | 3 | 13 | These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine for injectable suspension, for intramuscular use Initial U.S. Approval: 2008 | 20260428 |
| e7a819d7-a597-4c91-9078-7cd20ac34410 | Pentacel (with vIPV) vaccine 0.5 ML Injection [PSN] · 0.5 ML acellular pertussis vaccine, inactivated 96 UNT/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 68 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML Injection [Pentacel] [SBD] · Pentacel DTaP-IPV/Hib (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus (vIPV) and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)) 0.5 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use Pentacel safely and effectively. See full prescribing information for Pentacel. Pentacel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine Suspension for Intramuscular Injection Initial U.S. Approval: 2008 | 20250516 |